BIOCONNSEBiocon Limited· PharmaceuticalsMinimalNeutral
Announced Sat, 9 May · 16:20 IST

Biocon Limited has informed the Exchange about Copy of Newspaper Publication on Postal Ballot Notice

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+6.6%1-day move
₹378.70
prior close
₹380.45
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.1-1.0-0.3+0.3+6.6+9.9+10.4+13.7+12.8+14.6+10.0+10.0+9.0
Up moveDown movePending
AI summary

Biocon Limited has published a Postal Ballot Notice seeking shareholder approvals through remote e-voting. Key items include: (1) revision in remuneration of Executive Chairperson Ms. Kiran Mazumdar-Shaw, (2) appointment of Mr. Shreehas Pradeep Tambe as CEO & Managing Director, (3) issuance of equity shares on preferential basis for non-cash consideration, and (4) appointment/re-appointment of 8 directors including 6 Independent Directors. The e-voting period runs from May 9, 2026 to June 7, 2026, with results to be declared by June 9, 2026. The cut-off date for eligible voters was May 1, 2026.

Likely market impact

The appointment of a new CEO and multiple board changes signal a significant leadership transition at Biocon. Shareholders should review the proposals carefully as these changes could impact future company strategy and governance. The preferential equity issuance may affect shareholding structure.